文献速递肝病

2023年肝移植:现状报告、当前与未来挑战

Liver Transplantation 2023: Status Report, Current and Future Challenges.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-04-20

本文综述肝移植现状与未来挑战,包括扩大供体来源、肝硬化病因变迁(酒精性及非酒精性/代谢性脂肪性肝病需求增加、病毒性肝炎减少但乙型肝炎在流行区仍重要)、患者选择与疾病复发预防策略。

要点

  • 肝移植为肝硬化并发症及T2期肝细胞癌患者提供挽救生命的治疗。
  • 器官需求远超供应,增加可用的 deceased 供体及替代供体来源是主要焦点。
  • 肝硬化病因变迁:酒精性及非酒精性/代谢性脂肪性肝病移植需求增加,病毒性肝炎减少。

核心结论

  • 肝移植为肝硬化并发症及T2期肝细胞癌患者提供挽救生命的治疗,但器官需求远超供应。
  • 肝硬化病因随时间变化,酒精性及非酒精性/代谢性脂肪性肝病移植需求增加,病毒性肝炎减少。
  • 乙型肝炎在高度流行国家仍是重要移植指征。

研究设计与样本

  • 综述,检索范围未报告。

主要发现

  • 器官需求远超供应,创新重点为增加可用的 deceased 供体及替代供体来源。
  • 酒精性及非酒精性/代谢性脂肪性肝病移植增加,引起对患者选择及预防疾病复发策略的关注。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Liver transplantation offers live-saving therapy for patients with complications of cirrhosis and stage T2 hepatocellular carcinoma. The demand for organs far outstrips the supply, and innovations aimed at increasing the number of usable deceased donors as well as alternative donor sources are a major focus. The etiologies of cirrhosis are shifting over time, with more need for transplantation among patients with alcohol-associated liver disease and nonalcoholic/metabolic fatty liver disease and less for viral hepatitis, although hepatitis B remains an important indication for transplant in countries with high endemicity. The rise in transplantation for alcohol-associated liver disease and nonalcoholic/metabolic fatty liver disease has brought attention to how patients are selected for transplantation and the strategies needed to prevent recurrent disease. In this review, we present a status report on the most pressing topics in liver transplantation and future challenges.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Terrault NA, Francoz C, Berenguer M, et al. Liver Transplantation 2023: Status Report, Current and Future Challenges. Clin Gastroenterol Hepatol. 2023. PMID: 37084928. doi:10.1016/j.cgh.2023.04.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。